- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
ALAFY
PAR
Week ended 24 Jul 2026
Weekly Investor Report
AFYREN SAS · Basic Materials · Specialty Chemicals
Latest close
2.82 EUR
1.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 3.3% above the Trend Line and sits at 64.5% of its 52-week range. The latest completed week returned 1.4%, after a 6.4% four-week move. The latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal.
Setup score
49
out of 100
Latest Close
2.82 EUR
24 Jul 2026
1W Return
1.4%
latest completed week
4W Return
6.4%
short-term follow-through
12W Return
13.7%
quarterly tape
Trend Breadth
51.9%
27 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 35.44% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.4%
Latest completed week; four-week move 6.4%.
Indicator stack
29/75
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 35.44%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
58/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 3.3% above the Trend Line and sits at 64.5% of its 52-week range. The latest completed week returned 1.4%, after a 6.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3712-week average 0.38
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.37Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.4% over four weeks, 13.7% over 12 weeks, and 16.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year27
Trend breadth51.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.45Latest activity-pressure read.
Pressure change212.8%Four-week change in activity pressure.
Leadership3.58Latest relative-leadership reading.
RS change260.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment58/100
Weighted news tone is neutral across 2 relevant articles.
1 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.8%Distance below the 52-week high.
13-week volatility8.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher11 of 2615 weeks finished lower.
Best week+19.0%Week of 19 Jun.
Worst week-11.4%Week of 17 Apr.
Latest week+1.4%Week of 24 Jul.
Shape of recent returns
Strong gains5
Modest gains6
Flat weeks0
Modest losses8
Sharp losses7
Recent vol8.3%13-week weekly-return volatility.
Base vol6.9%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Basic Materials
4-week rank7 / 31
Group average1.1%
Trend breadth29.0%
Trend29.0%active weekly trend signals
MD32.3%positive activity pressure
RS41.9%positive relative leadership
Four-week leaders
IndustryFR Specialty Chemicals
4-week rank2 / 11
Group average-0.6%
Trend breadth36.4%
Trend36.4%active weekly trend signals
MD27.3%positive activity pressure
RS45.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis30/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 6/12.
Activity pressure 0.37; No reversal markers Next-Week ExpectancyNegative 35.44%Next-week expectancy is negative with a 35.44% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment58/100Weighted news tone is neutral across 2 relevant articles.
A New Financial Analyst Initiates Coverage of the AFYREN Stock With a Positive Recommendation Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 2.82 EUR | 1.4% | 2.73 EUR | 2.58 EUR | 0.45 | 3.58 | 37.5K | Off |
| 17 Jul 2026 | 2.78 EUR | 1.1% | 2.73 EUR | 2.60 EUR | 0.34 | 2.69 | 48.1K | Off |
| 10 Jul 2026 | 2.75 EUR | -2.5% | 2.73 EUR | 2.62 EUR | 0.24 | 1.86 | 42.7K | Off |
| 3 Jul 2026 | 2.82 EUR | 6.4% | 2.72 EUR | 2.64 EUR | -0.07 | 2.59 | 44.6K | Off |
| 26 Jun 2026 | 2.65 EUR | -8.0% | 2.72 EUR | 2.66 EUR | -0.40 | -2.24 | 80.6K | Off |
| 19 Jun 2026 | 2.88 EUR | 19.0% | 2.73 EUR | 2.68 EUR | -0.59 | 5.58 | 21.3K | Off |
| 12 Jun 2026 | 2.42 EUR | 0.4% | 2.71 EUR | 2.69 EUR | -0.79 | -10.68 | 3.6K | Off |
| 5 Jun 2026 | 2.41 EUR | -8.7% | 2.70 EUR | 2.71 EUR | -0.64 | -9.89 | 26.1K | Off |
| 29 May 2026 | 2.64 EUR | 2.1% | 2.70 EUR | 2.72 EUR | -0.71 | -1.33 | 47.9K | Off |
| 22 May 2026 | 2.58 EUR | -3.9% | 2.69 EUR | 2.74 EUR | -0.67 | -2.95 | 62.2K | Off |
| 15 May 2026 | 2.69 EUR | 13.5% | 2.68 EUR | 2.75 EUR | -0.71 | 3.30 | 196.4K | Off |
| 8 May 2026 | 2.37 EUR | -4.4% | 2.66 EUR | 2.77 EUR | -1.01 | -10.21 | 97.5K | Off |
| 1 May 2026 | 2.48 EUR | 13.5% | 2.67 EUR | 2.78 EUR | -1.05 | -5.67 | 321.4K | Off |
| 24 Apr 2026 | 2.19 EUR | -3.3% | 2.67 EUR | 2.80 EUR | -1.18 | -16.88 | 201.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.